India, Aug. 8 -- It has been established that there is a major public health problem in India with a population of more than 1.4 billion. Access to inexpensive medication constitutes a great difficulty. An increase in medication costs affects the bills of families in low- and middle-income countries. Today, 60% of people in India are unable to get timely access to such essential drugs, and nearly all health care leads to a self-paid out-of-pocket expenditure, while only 15% are insured, thus contributing to the expense.

Generic medicines have a therapeutic equivalence with their trademarked counterparts and conform to bioequivalence standards. Depending upon the therapeutic areas, they give maximum savings on existing branded counterpart...